Form D Explorer
Artax Biopharma, Inc. · CIK 1587661

Report a data issueCitable research briefCompare issuerPrivate research collection

Artax Biopharma, Inc.

CIK 1587661 · Corporation · Inc. DELAWARE · CAMBRIDGE, Massachusetts · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
0
Amendments
2
Activity
Jul 29, 2025
through May 5, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 29, 2025 · D/AMay 5, 2026 · D/ALater minus earlier
Reported offering amount$11,000,000$19,000,000$8,000,000
Reported amount sold$11,000,000$19,000,000$8,000,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001587661-25-000003 · Later SEC source: 0001587661-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · May 5, 2026

Reported offering amount
$19,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$19,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)